Graduate School to offer cancer prevention certificate
By Elizabeth Allen
SAN ANTONIO (April 1, 2014) — The Graduate School of Biomedical Sciences is now offering a Graduate Certificate in Cancer Prevention (CCP) that will focus on the risks for cancer in South Texas.
“Understanding cancer risks in South Texas, with its large Hispanic population and higher liver cancer rates, will help health professionals in our quest to lower cancer rates here and, eventually, everywhere,” said Michael Wargovich, Ph.D., director of the CCP program.
Dr. Wargovich holds the Cancer Therapy & Research Center's Cancer Center Council Distinguished Chair in Oncology and is a professor of molecular medicine in the School of Medicine at the UT Health Science Center San Antonio.
The CCP program can be an alternative for health professionals who do not have time to complete the requirements of an advanced master’s or doctoral degree, and can be a supplement to the education of graduate students, fellows and others who want additional training in the evolving discipline of cancer prevention.
The 12-semester-credit-hour program offers relevant coursework including biostatistics, topics in cancer prevention, epidemiology and clinical trial design and analysis.
To be eligible, participants need sufficient educational background and experience in the biological or biomedical sciences. Most students will have a health professional degree or a bachelor’s or master’s degree with an emphasis in a health-related discipline.
How to apply
The deadline for applications for the fall semester is May 15, 2014. For more information, visit http://iims.uthscsa.edu/education-Certificate-in-Cancer-Prevention.
Gail Tomlinson, M.D., Ph.D., interim director of the Greehey Children’s Cancer Research Institute (GCCRI), is co-director of the CCP program. The program coordinator is Monica Treviño, Ph.D., coordinator of minority programs at the CTRC.
Contact Dr. Wargovich at 210-567-5230 or Dr. Treviño at 210-450-1437 for questions about the CCP program.
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI)-designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.
HOME [HSC NEWS]
| About UTHSCSA
| News Releases | Mission
Magazine | Grand Rounds Newly
Granted | Submit News | HSC
News Archive | Video Index